Home / Health / Fauci has previously argued virus trials are worth the risk of the epidemic.

Fauci has previously argued virus trials are worth the risk of the epidemic.

Dr. Anthony Fosy has previously argued that conducting experiments with infectious viruses to enhance the capabilities was worth the risk, although the work could inadvertently lead to an epidemic. But it was revealed on Friday.

The country’s chief medical advisor wrote in the American Society for Microbiology in October 2012 on the public health benefit of reaping the benefits of viral trials, which focus on tackling the virus and making it stronger as long as it is. Regulate significantly

In the article, first reported by The Australian, Fauci also noted that discontinuation of the study should continue until researchers find a more transparent approach.

Efficiency-enhancing trials are a type of work performed at the Wuhan Institute of Virology when the COVID-1

9 outbreak first started in China in late 2019, and some experts feared a laboratory accident was “ the worst. ” What led to the global pandemic that killed 3.4 million people worldwide.

In a 2012 paper, Fauci acknowledged that risky research could lead to serious laboratory accidents. But opportunities are rare, and this job is “important” because it helps the scientific community prepare for natural outbreaks.

Dr. Anthony Fauci
“The benefits of such trials and the knowledge they gain outweigh the risks,” Fauci said.
POOL / AFP via Getty Images

“In an event that is unlikely to happen But what is possible if that scientist was infected with the virus, which would lead to an outbreak and eventually cause an epidemic, ”he wrote at the time.

“Many people ask reasonable questions: Given the possibility of this situation – whether it is far away – should the first trial and / or publish it in the first place, and what processes are involved in this decision? Scientists working in this field might say – as I have said – the benefits of such experiments and the knowledge they gain outweigh the risks. ”

He wrote that there was “More chances” that the outbreak will occur naturally and “The need to stay ahead of such threats is the primary reason for conducting potentially risky trials.”

Wuhan Scientist
Efficacy trials were performed at the Wuhan Institute of Virology when the COVID-19 outbreak first began in China in late 2019.
Chinese feature

However, he noted that the scientific community “must respect that there are real and legal concerns about this type of research both locally and globally.”

“We cannot expect those with these concerns to just take us, the scientific community, in our words, that the benefits of this work outweigh the risks, and we cannot ignore the call for them to be transparent. More and more concerns about conflicts of interest and they An interactive effort to respond to whether these experiments should be performed in the first place, ”wrote Fauci.

“We in the scientific community who believe in the merits of this work have a responsibility to deal with these concerns carefully and respectfully.”

Wuhan Virology Institute
The Wuhan Institute of Virology is conducting a performance-enhancing experiment when the COVID-19 outbreak first began in China in late 2019.
AFP via Getty Images

The best thesis of the opinion piece is to show support for pauses in research, the benefits associated with the “highly pathogenic” H5N1 influenza virus transmission capacity. The moratorium should continue “await the resolution of important policy questions about the reasons for conducting such trials and the best way to report their results.”

Fauci did not immediately return a request for comment.

Source link